Overview

Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
This study investigates the response of vaginal and cervical tissue after exposure to three vaginal products: hydroxyethyl cellulose (HEC) placebo, nonoxynol-9 (N9) and imiquimod (IMQ) cream.
Phase:
Phase 2
Details
Lead Sponsor:
CONRAD
Treatments:
Imiquimod
Nonoxynol